These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23008470)

  • 1. Evolution of hypertrophic cardiomyopathy to a contemporary treatable disease.
    Maron BJ; Braunwald E
    Circulation; 2012 Sep; 126(13):1640-4. PubMed ID: 23008470
    [No Abstract]   [Full Text] [Related]  

  • 2. Ventricular fibrillation during sleep in an adolescent with hypertrophic cardiomyopathy: the difficulty of risk stratification and the power of the cardioverter-defibrillator.
    Boriani G; Biffi M; Rapezzi C; Coccolo F; Branzi A; Spirito P
    Int J Cardiol; 2004 Oct; 97(1):143-4. PubMed ID: 15336824
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
    Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P
    N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
    Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
    Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of an implantable defibrillator for the prevention of sudden death in hypertrophic cardiomyopathy].
    Hentati M; Ben Ameur I; Kechida Z; Charfeddine H; Hached L; Grati Z; Kammoun S
    Tunis Med; 2003; 81 Suppl 8():675-9. PubMed ID: 14608758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-modality imaging in an exceptional case of aborted sudden cardiac death.
    Sonck J; Tanaka K; Czapla J; Vanderhasselt T; Kayaert P; Scott B; Sutherland G; Van Camp G
    Int J Cardiol; 2014 Feb; 171(2):e57-8. PubMed ID: 24365616
    [No Abstract]   [Full Text] [Related]  

  • 8. [Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy].
    Spirito P; Piccininno M
    Ital Heart J Suppl; 2000 Jun; 1(6):840-1. PubMed ID: 11204022
    [No Abstract]   [Full Text] [Related]  

  • 9. Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status.
    Maron BJ; Maron MS; Lesser JR; Hauser RG; Haas TS; Harrigan CJ; Appelbaum E; Main ML; Roberts WC
    Am J Cardiol; 2008 Feb; 101(4):544-7. PubMed ID: 18312775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Images in cardiovascular medicine. Rapid progression of extreme septal hypertrophic cardiomyopathy.
    Jefferies JL; Moreira W; Massumi A; Stainback RF
    Circulation; 2003 Nov; 108(19):e136. PubMed ID: 14609999
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypertrophic cardiomyopathy with midcavitary obstruction: another substrate for ventricular tachycardia?
    Gerstenfeld EP
    J Cardiovasc Electrophysiol; 2010 Sep; 21(9):1000-1. PubMed ID: 20487115
    [No Abstract]   [Full Text] [Related]  

  • 12. Ventricular tachyarrhythmia associated with hypertrophic cardiomyopathy: incidence, prognosis, and relation to type of hypertrophy.
    Furushima H; Chinushi M; Iijima K; Sanada A; Izumi D; Hosaka Y; Aizawa Y
    J Cardiovasc Electrophysiol; 2010 Sep; 21(9):991-9. PubMed ID: 20487113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy].
    Primo JJ
    Rev Port Cardiol; 2001 Feb; 20(2):225-8. PubMed ID: 11293882
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term follow-up of implantable cardioverter defibrillator therapy for hypertrophic cardiomyopathy.
    Jayatilleke I; Doolan A; Ingles J; McGuire M; Booth V; Richmond DR; Semsarian C
    Am J Cardiol; 2004 May; 93(9):1192-4. PubMed ID: 15110224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk assessment with cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.
    Gosling OE; Bellenger N; Spurrell P
    Heart; 2009 Nov; 95(22):1843. PubMed ID: 19875370
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of family history of sudden death in risk stratification and prevention of sudden death with implantable defibrillators in hypertrophic cardiomyopathy.
    Bos JM; Maron BJ; Ackerman MJ; Haas TS; Sorajja P; Nishimura RA; Gersh BJ; Ommen SR
    Am J Cardiol; 2010 Nov; 106(10):1481-6. PubMed ID: 21059440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Noseworthy PA; Rosenberg MA; Fifer MA; Palacios IF; Lowry PA; Ruskin JN; Sanborn DM; Picard MH; Vlahakes GJ; Mela T; Das S
    Am J Cardiol; 2009 Jul; 104(1):128-32. PubMed ID: 19576333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcoronary ablation of septal hypertrophy does not alter ICD intervention rates in high risk patients with hypertrophic obstructive cardiomyopathy.
    Lawrenz T; Obergassel L; Lieder F; Leuner C; Strunk-Mueller C; Meyer Zu Vilsendorf D; Beer G; Kuhn H
    Pacing Clin Electrophysiol; 2005 Apr; 28(4):295-300. PubMed ID: 15826262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypertrophic cardiomyopathy with two episodes of recuperated sudden death. Report of the first implantable defibrillator cardioverter inserted in Chile].
    Zalaquett R; Fajuri A; Irarrázaval MJ; Neghme R; Vergara I; Sacco C; Dubernet J; Corbalán R
    Rev Med Chil; 1994 Oct; 122(10):1171-7. PubMed ID: 7659885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indications for implantable cardioverter defibrillator (ICD) therapy. Study Group on Guidelines on ICDs of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology.
    Hauer RN; Aliot E; Block M; Capucci A; Lüderitz B; Santini M; Vardas PE;
    Eur Heart J; 2001 Jul; 22(13):1074-81. PubMed ID: 11428848
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.